Ginkgo Bioworks Holdings (DNA) Competitor Comparison
We are evaluating the key criteria listed to compare Ginkgo Bioworks Holdings (DNA) against its competitors in the Biotechnology industry.
Market Capitalization
55 / 377Gross Profits
25 / 285Total Revenue
38 / 309EBITDA
341 / 345Free Cashflow
248 / 361Quick Ratio
142 / 366Earnings per Share
70 / 367Dividend yield
0 / 5Total Cash
22 / 367Performance 3 years
331 / 377Performance 5 years
317 / 377Performance 10 years
291 / 377Linearity 3 years
267 / 377Linearity 5 years
247 / 377Linearity 10 years
226 / 377Total Rank
139 / 377Dividend Rank
145 / 377Valuation Rank
4 / 377Piotroski Rank
288 / 377Muliplier Rank
37 / 377Performance 10 years - DNA ranking 291 / 377
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.